-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Kiromic Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q3 2024.
- Kiromic Biopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was 326 %, a 13.7% decline year-over-year.
- Kiromic Biopharma, Inc. annual Return On Equity for 2023 was 299 %.
- Kiromic Biopharma, Inc. annual Return On Equity for 2022 was -528 %, a 303% decline from 2021.
- Kiromic Biopharma, Inc. annual Return On Equity for 2021 was -131 %, a 69.4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)